MEDFORD, MA: Biocell Center, a technology company that operates amniotic-fluid stem-cell banks in the US and Europe, is working with GCI Health to raise awareness with mothers-to-be about amniotic fluid banking.
The firm began working with Biocell in early 2011, following a competitive bid, said Kate Torchilin, CEO of Biocell, noting that it is the “right time to go out with this message” in the US. The ongoing consumer awareness program targets expecting parents in the US with an integrated communications push that includes media relations and social media.
The account is led by VP Sarah Smith and CEO Wendy Lund out of GCI Health's New York office. Torchilin declined to provide budget.
Biocell, which first opened operations in Italy and Switzerland, opened its first facility in the US in 2009. The company said that stored amniotic fluid stem cells can be used to treat injuries and wounds later in life.